PHAT as of Oct 31 · 14:28 ET
PHATNasdaqPharmaceutical Preparations
Phathom Pharmaceuticals, Inc. · Brief
Next report
67 days
Jan 6 · after closeest.Q4 FY26
Expected move
No implied move.
2 of 7≥ implied
- avg implied
- ±22.2%
- avg realized
- ±11.8%
May 1 '25±17.4%▼−21.68%×1.25
Aug 7 '25±21.8%▲+8.29%×0.38
Oct 30 '25±31.1%▼−1.63%×0.05
Jan 7 '26±12.0%▼−13.72%×1.14
Feb 26 '26±27.6%▲+10.06%×0.36
Q1 FY26±17.4%▼−4.92%×0.28
Q2 FY26±28.3%▼−22.42%×0.79
Q3 FY26—▼−0.96%—
quarterimplied−35%0+35%realized×
Q3 FY26—▼−0.96%—
Q2 FY26±28.3%▼−22.42%×0.79
Q1 FY26±17.4%▼−4.92%×0.28
Feb '26±27.6%▲+10.06%×0.36
Jan '26±12.0%▼−13.72%×1.14
Oct '25±31.1%▼−1.63%×0.05
2 older reports
Aug '25±21.8%▲+8.29%×0.38
May '25±17.4%▼−21.68%×1.25
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Jan 6 report · est.—
Linked exposure
PHAT report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.